Name	Cefepime
Description	Cefepime (BMY-28142) is a cephalosporin antibiotic with antimicrobial activity, induces neurotoxicity, inhibits both Gram-positive and Gram-negative, and can be used in the study of anaerobic bacteria.
In vivo	METHODS: Mice were given different doses of cisplatin (0, 10, 14, 18, 22, and 26 mg/kg) three days before intraperitoneal (ip) injection of 80 mg/kg cefepime to determine the dose of cisplatin that would not affect mouse survival and achieve human-like serum concentrations of cefepime. RESULTS: The half-life of cefepime was significantly prolonged at cisplatin doses of 18 and 22 mg/kg. [1]
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	DMSO : 120 mg/mL (249.71 mM, Sonication is recommended. H2O : 80 mg/mL (166.47 mM), Sonication is recommended.
Keywords	Cefepime
Inhibitors Related	Neomycin sulfate \| Ampicillin sodium \| Kanamycin sulfate \| Sulfamethoxazole sodium \| Doxycycline \| Dimethyl sulfoxide

Cefepime NEW

Product Introduction